Insulin glargine with step-wise addition of insulin glulisine or with one injection of insulin glulisine vs a twice-daily premixed insulin regimen (insulin aspart mix 70/30) in adult subjects with type-2 diabetes failing dual or triple therapy with oral agents.

Trial Profile

Insulin glargine with step-wise addition of insulin glulisine or with one injection of insulin glulisine vs a twice-daily premixed insulin regimen (insulin aspart mix 70/30) in adult subjects with type-2 diabetes failing dual or triple therapy with oral agents.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2011

At a glance

  • Drugs Insulin aspart/insulin protamine aspart; Insulin glargine; Insulin glulisine
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
    • 12 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes (EASD-2011).
    • 28 Jun 2011 Patient reported outcomes presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top